中英双语新闻:哈佛研究表明现有疫苗能有效预防Omicron重症

中英双语新闻:哈佛研究表明现有疫苗能有效预防Omicron重症
Existing vaccines effective against severe Omicron, study suggests
哈佛:现有疫苗能有效预防Omicron重症

中英双语新闻:哈佛研究表明现有疫苗能有效预防Omicron重症

Cellular immunity elicited by the BioNTech/Pfizer and Johnson & Johnson Covid-19 vaccines is effective against the Omicron coronavirus variant, according to a study, suggesting vaccines will protect against severe disease even if the antibody responses against the strain are not as strong or durable.

一项研究表明,由BioNTech/辉瑞(Pfizer)和强生(Johnson & Johnson)新冠疫苗引发的细胞免疫对Omicron变种有效,这似乎表明现有疫苗能够预防重症——即便针对该病毒株的抗体反应不那么强烈或持久。

The findings, contained in a new Harvard medical school study, add to evidence that the current vaccines hold up against severe Covid outcomes, and could help health authorities to decide whether to switch to Omicron-targeted jabs.

哈佛医学院(Harvard Medical School)的这项新研究结果带来更多证据,证明现有疫苗能够预防新冠重症,并且可能有助于卫生当局决定是否改用Omicron靶向疫苗。

“These data suggest that current vaccines may provide considerable protection against severe disease with the Sars-Cov-2 Omicron variant despite the substantial reduction of neutralising antibody responses,” the researchers wrote in the study made public on Monday. The paper has not been peer-reviewed yet.

“这些数据似乎表明,现有疫苗可能对SARS-CoV-2 Omicron变种造成的重症提供相当大的预防保护,尽管中和抗体反应显著减少,”研究人员在周一公布的研究报告中写道。该报告尚未经过同行评审。

发表回复

您的电子邮箱地址不会被公开。

网站地图